Skip to main content
. 2021 May 19;11:648139. doi: 10.3389/fonc.2021.648139

Figure 1.

Figure 1

Immune checkpoints involved in T cell inactivation. Cancer cells evade the host immune system through upregulation of immune checkpoints composed of the ligands on the cancer cell and the respective receptors on the CD8+ T cell. These ligand/receptor pairs include PDL1/PD1, CD80/CD86/CTLA4, MHC II/LAG3, CD155/TIGIT, and GAL9/TIM3. In addition, VTCN1 is also found on TNBC cells, although its receptor on T cells is not known.